Company

ReVision Therapeutics, Inc.

ReVision Therapeutics develops medicines for retinal disorders and age-related vision loss.

About

Founded in 2010 and based in San Diego, US, ReVision Therapeutics develops therapies intended to preserve vision, with a focus on retinal disorders. It raised USD 0.50 million in Series B funding from Avalon Ventures on December 19, 2011.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in